These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19647907)

  • 1. Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-(2-(2-methoxy phenoxy)ethylamino)propan-2-ol analogs and its enantiomers. Part 2.
    Groszek G; Nowak-Król A; Wdowik T; Swierczyński D; Bednarski M; Otto M; Walczak M; Filipek B
    Eur J Med Chem; 2009 Dec; 44(12):5103-11. PubMed ID: 19647907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol and its enantiomers. Part 1.
    Groszek G; Bednarski M; Dybała M; Filipek B
    Eur J Med Chem; 2009 Feb; 44(2):809-17. PubMed ID: 18599160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and adrenolytic activity of new propanolamines.
    Groszek G; Bajek A; Bis A; Nowak-Król A; Bednarski M; Siwek A; Filipek B
    Molecules; 2010 May; 15(6):3887-904. PubMed ID: 20657415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantioselective LC/ESI-MS/MS analysis and pharmacokinetic and tissue distribution study of (2RS)-1-(7-methoxy-1H-indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)-propan-2-ol in rats.
    Walczak M; Szymura-Oleksia J; Groszek G
    Chirality; 2012 Aug; 24(8):591-9. PubMed ID: 22714390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Pharmacological Activity of a New Series of 1-(1H-Indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol Analogs.
    Bednarski M; Otto M; Dudek M; Kołaczkowski M; Bucki A; Siwek A; Groszek G; Maziarz E; Wilk P; Sapa J
    Arch Pharm (Weinheim); 2016 Mar; 349(3):211-23. PubMed ID: 26853441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol.
    Beattie K; Phadke G; Novakovic J
    Profiles Drug Subst Excip Relat Methodol; 2013; 38():113-57. PubMed ID: 23668404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of liquid chromatography-tandem mass spectrometry method for the analysis of new nonselective beta-adrenergic blocker 1-(1-H-indol-4-yloxy)-3-{[2-(2-methoxy phenoxy)ethylo]amino}propan-2-ol (2F109) in rat plasma.
    Walczak M; Szafarz M; Szymura-Oleksiak J; Groszek G; Bednarski M; Filipek B
    Chirality; 2007 Jul; 19(7):536-41. PubMed ID: 17457833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic activity in occlusion-reperfusion model of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino} propan-2-ol and its enantiomers.
    Bednarski M; Otto M; Dudek M; Siwek A; Zygmunt M; Knutelska J; Nowiński L; Groszek G; Sapa J
    Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):81-7. PubMed ID: 26384857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereospecific effects of benzo[d]isothiazolyloxypropanolamine derivatives at beta-adrenoceptors: synthesis, chiral resolution, and biological activity in vitro.
    Comini M; Pozzoli C; Incerti M; Rossi D; Collina S; Azzolina O; Di Vittorio E; Morini G; Poli E
    Chirality; 2009 Feb; 21(2):284-91. PubMed ID: 18537163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoloxypropanolamine analogues as 5-HT(1A) receptor antagonists.
    Krushinski JH; Schaus JM; Thompson DC; Calligaro DO; Nelson DL; Luecke SH; Wainscott DB; Wong DT
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5600-4. PubMed ID: 17804228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological activity of some 1-alkylamino-3-(2'-methoxy-4'-diethylcarbamoyl-phenoxy)propan-2-ols.
    Monforte P; Basile M; Previtera T; Larizza A; Marmo E; De Gennaro G; Montinaro C; Filippelli W; Montanaro CS; Marfella A; Larizza D
    Farmaco Sci; 1983 Mar; 28(3):173-86. PubMed ID: 6133779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-(9H-Carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol hemihydrate: a carvedilol solvatomorph.
    Díaz F; Benassi A; Quintero M; Polla G; Freire E; Baggio R
    Acta Crystallogr C; 2011 Jul; 67(Pt 7):o222-5. PubMed ID: 21727629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary metabolites identification of a novel compound with β-adrenolytic activity.
    Walczak M; Suraj-Prażmowska J; Kuś K; Kij A; Groszek G
    Pharmacol Rep; 2021 Oct; 73(5):1373-1389. PubMed ID: 34050907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective analysis of carvedilol in human plasma and urine using HPLC after chiral derivatization.
    Peccinini RG; Ximenes VF; Cesarino EJ; Lanchote VL
    Biopharm Drug Dispos; 2008 Jul; 29(5):280-8. PubMed ID: 18551504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
    Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
    Chirality; 1989; 1(4):265-70. PubMed ID: 2577144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Maciag D; Filipek B; Malawska B
    Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselective pharmacokinetic-pharmacodynamic modelling of carvedilol in a N-nitro-l-arginine methyl ester rat model of secondary hypertension.
    Di Verniero CA; Bertera F; Buontempo F; Bernabeu E; Chiappetta D; Mayer MA; Bramuglia GF; Taira CA; Höcht C
    J Pharm Pharmacol; 2010 Jul; 62(7):890-900. PubMed ID: 20636877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of carvedilol enantiomers in human plasma using chiral stationary phase column and liquid chromatography with tandem mass spectrometry.
    Poggi JC; Da Silva FG; Coelho EB; Marques MP; Bertucci C; Lanchote VL
    Chirality; 2012 Mar; 24(3):209-14. PubMed ID: 22271587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic properties of carvedilol in fructose hypertensive rats.
    Bertera F; Di Verniero CA; Mayer MA; Chiappetta D; Buontempo F; Polizio AH; Taira CA; Höcht C
    Xenobiotica; 2012 Feb; 42(2):206-19. PubMed ID: 21892881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.